PROGRAM OBJECTIVES
After attending this educational activity, participants will be able to:
- Recognize the many types of T-cell lymphoma and their natural history and prognosis;
- Discuss the treatment of peripheral T-cell lymphoma;
- Discuss the approach to a young patient with relapsed follicular lymphoma;
- Review the critical biologic pathways underlying lymphomagenesis and how they can be targeted;
- Understand the current recommendations regarding the use of PET and other imaging modalities in NHL and Hodgkin lymphoma.
SCIENTIFIC PROGRAM
Friday, April 23, 2010
12:00pm – 5:00pm
Registration and Information Desk Open
2:30pm - 6:00pm
Exhibition Hall Open
1:00pm – 3:00pm
Session Topic
Critical Pathways in Lymphoma: An Emphasis on New Targets
1:00pm – 1:10pm
Welcome and Overview
1:10pm – 1:40pm
Sandeep S. Dave, MD
Duke University
MiRNA in NHL
1:40pm – 2:10pm
Stephen Ansell, MD, PhD
Mayo Clinic
The Future of Monoclonal Antibodies in Lymphoma: What’s Next?
2:10pm – 2:40pm
Sonali Smith, MD
University of Chicago
PI3K/Akt/Mtor Pathway in Lymphoma: Progress Report and Future Outlook
2:40pm – 3:00pm
Ari Melnick, MD
Albert Einstein College of Medicine
Targeting The Germinal Center: Why and How?
3:00pm – 3:40pm
Refreshment Break
3:40pm – 5:00pm
Session Topic
Hematopathology: What the Clinician Needs to Know
3:40pm – 4:10pm
John Anastasi, MD
University of Chicago
Grey-Zone Lymphomas
4:10pm – 4:40pm
Amy Chadburn, MD
Northwestern University
Viral Etiology of Lymphoma
4:40pm – 5:00pm
Abstract/Poster Highlights
5:00pm – 6:00pm
Welcome Reception and Poster Viewing
Saturday, April 24, 2010
7:00am – 4:00pm
Registration & Information Desk Open
7:00am – 1:30pm
Exhibition Hall Open
7:00am – 8:00am
Continental Breakfast
8:00am – 9:40am
Session Topic
T-NHL, HIV-Lymphoma
8:00am – 8:10am
Welcome and Overview
8:00am – 8:40am
Denis Weisenberger, MD
University of Nebraska
T-NHL: Biology and Prognostic Factors
8:40am – 9:10am
Steve Horwitz, MD
Memorial-Sloan Kettering Cancer Center
How I Treat: Systemic T-NHL
9:10am – 9:40am
Joseph Sparano, MD
Albert Einstein College of Medicine
HIV and NHL in 2010: State of the Art Approach To Front-Line and Relapsed Disease
9:40am – 10:20am
Refreshment Break
10:20am – 12:20am
Session Topic
Debates in Lymphoma
10:20am – 11:20am
Peter McLaughlin, MD
MD Anderson Cancer Center
and
Leo I. Gordon, MD
Northwestern University
Purine Analogs in Indolent Lymphoma: Pro Vs. Con
11:20am – 12:20pm
Brad Kahl, MD
University of Wisconsin
and
Scott Smith, MD
Loyola University
Management of Very High Risk DLBCL: Is There Still a Role for Front-Line Transplant
12:20pm – 1:10pm
Lunch
1:10pm – 3:30pm
Session Topic
Special Topics in Lymphoma
1:10pm – 1:40pm
Steven Bernstein, MD
University of Rochester
CNS Prophylaxis: Who and How?
1:40pm – 2:10pm
Philippe Solal-Celigny, MD, PhD
Laboratoire Central D’Hématologie, Centre Jean Bernard
Keynote Lecture: Prognosis in Follicular Lymphoma in the Modern Era
2:30pm – 3:30pm
Expert Panel
Case Discussions: HL, PMBL, Other
3:30pm
Conference Adjourn
Page last update: February 4, 2010
